CN102746306B - 别嘌醇类衍生物及其制备方法和用途 - Google Patents
别嘌醇类衍生物及其制备方法和用途 Download PDFInfo
- Publication number
- CN102746306B CN102746306B CN201210234747.4A CN201210234747A CN102746306B CN 102746306 B CN102746306 B CN 102746306B CN 201210234747 A CN201210234747 A CN 201210234747A CN 102746306 B CN102746306 B CN 102746306B
- Authority
- CN
- China
- Prior art keywords
- pyrimidine
- pyrazoles
- chloro
- ethyl
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 0 C[n]1ncc2c(*)ncnc12 Chemical compound C[n]1ncc2c(*)ncnc12 0.000 description 2
- OFCNXPDARWKPPY-UHFFFAOYSA-N Oc1c(cn[nH]2)c2ncn1 Chemical compound Oc1c(cn[nH]2)c2ncn1 OFCNXPDARWKPPY-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Description
Claims (6)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210234747.4A CN102746306B (zh) | 2012-07-09 | 2012-07-09 | 别嘌醇类衍生物及其制备方法和用途 |
PCT/CN2012/078732 WO2014008673A1 (zh) | 2012-07-09 | 2012-07-17 | 别嘌醇类衍生物及其制备方法和用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210234747.4A CN102746306B (zh) | 2012-07-09 | 2012-07-09 | 别嘌醇类衍生物及其制备方法和用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102746306A CN102746306A (zh) | 2012-10-24 |
CN102746306B true CN102746306B (zh) | 2014-11-19 |
Family
ID=47026847
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210234747.4A Active CN102746306B (zh) | 2012-07-09 | 2012-07-09 | 别嘌醇类衍生物及其制备方法和用途 |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN102746306B (zh) |
WO (1) | WO2014008673A1 (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106986874B (zh) * | 2016-01-20 | 2019-09-24 | 西华大学 | (1H-吡唑[3,4-d]嘧啶)-4-氨基衍生物及其作为IDO抑制剂在药物制备中的用途 |
CN106749263A (zh) * | 2016-11-13 | 2017-05-31 | 曹艳 | 一种别嘌醇衍生物及其在制备抗肿瘤药物中的用途 |
CN106749265A (zh) * | 2016-11-13 | 2017-05-31 | 曹艳 | 一种别嘌醇衍生物及其在制备抗肿瘤药物中的用途 |
CN106749264A (zh) * | 2016-11-13 | 2017-05-31 | 曹艳 | 一种别嘌醇衍生物及其在制备抗肿瘤药物中的用途 |
US20210267984A1 (en) | 2018-09-03 | 2021-09-02 | Wei Zhu | Application of allopurinol in preparation of drug for treating cancer with high expression of paics gene |
CN112826821B (zh) * | 2021-02-23 | 2022-09-16 | 成都阿奇生物医药科技有限公司 | 别嘌呤醇类衍生物在制备预防和/或治疗糖尿病的药物中的用途 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW200400034A (en) * | 2002-05-20 | 2004-01-01 | Bristol Myers Squibb Co | Pyrazolo-pyrimidine aniline compounds useful as kinase inhibitors |
GB0326168D0 (en) * | 2003-11-10 | 2003-12-17 | Arrow Therapeutics Ltd | Chemical compounds |
GB0524436D0 (en) * | 2005-11-30 | 2006-01-11 | Novartis Ag | Organic compounds |
ES2610190T3 (es) * | 2007-11-28 | 2017-04-26 | Dana-Farber Cancer Institute, Inc. | Inhibidores de miristato de moléculas pequeñas de Bcr-abl y métodos de uso |
-
2012
- 2012-07-09 CN CN201210234747.4A patent/CN102746306B/zh active Active
- 2012-07-17 WO PCT/CN2012/078732 patent/WO2014008673A1/zh active Application Filing
Also Published As
Publication number | Publication date |
---|---|
CN102746306A (zh) | 2012-10-24 |
WO2014008673A1 (zh) | 2014-01-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102746306B (zh) | 别嘌醇类衍生物及其制备方法和用途 | |
EP2848620B1 (en) | Quinoxaline derivatives | |
CN107056772A (zh) | 基于cereblon配体诱导BET降解的双功能分子及其制备和应用 | |
CN101323591A (zh) | 一类5-位或6-位取代的萘酰亚胺化合物及抗肿瘤应用 | |
CN101558067B (zh) | 作为mtor抑制剂的2-甲基吗啉吡啶并、吡唑并和嘧啶并-嘧啶衍生物 | |
CN110627801B (zh) | 一类hdac抑制剂及其用途 | |
TWI760005B (zh) | 具有大環結構的含氟並雜環衍生物及其用途 | |
JP7041821B2 (ja) | アミノ置換窒素含有縮合環化合物、その調製方法及び使用 | |
CN106749513A (zh) | 基于vhl配体诱导bet降解的双功能分子及其制备和应用 | |
CN102746308B (zh) | 别嘌醇衍生物及其制备方法和用途 | |
CN103333119A (zh) | 1,2-二氢-6-甲基-4-取代氨基-5-嘧啶羧酸类化合物及其制备方法和用途 | |
CN109071462A (zh) | 喹唑啉衍生物或其盐和包含其的药物组合物 | |
CN102746307B (zh) | 1-n-苄基别嘌醇衍生物及其制备方法和用途 | |
CN102746309B (zh) | 1-N-乙基-4-N-2′-取代酰基肼-1H-吡唑[3,4-d]嘧啶类衍生物及其制备方法和用途 | |
CN110885332B (zh) | 一种PDEδ蛋白降解靶向嵌合体及其制备方法和应用 | |
CN103070868A (zh) | 一种含nh-1,2,3-三氮唑的ido抑制剂及其制备方法 | |
KR102394934B1 (ko) | Akt 억제제로서의 염 형태 및 이의 결정 형태 | |
KR20180083426A (ko) | 비스-피리다진 화합물 및 암 치료에서 이의 용도 | |
WO2023000708A1 (zh) | 一种多取代嘌呤类化合物及其制备方法和应用 | |
CN106986854B (zh) | 一种没药烷倍半萜结构类似物及其制备方法与应用 | |
CN110283174B (zh) | 一类PI3Kδ抑制剂及其用途 | |
CN110256465B (zh) | 一种含二氢吡喃并噻唑的2,4-二氨基嘧啶及其应用 | |
Heredia-Moya et al. | An improved synthesis of arsenic–biotin conjugates | |
Cao et al. | Crystalline camptothecin-20 (S)-O-propionate hydrate: a novel anticancer agent with strong activity against 19 human tumor xenografts | |
JP7118349B2 (ja) | c-MET阻害剤の結晶形、及びその塩形、並びに調製方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Allopurinol derivative and preparation method and application thereof Effective date of registration: 20181016 Granted publication date: 20141119 Pledgee: Luzhou Talents Innovation and entrepreneurship equity investment fund partnership (L.P.) Pledgor: SICHUAN GUOKANG PHARMACEUTICAL Co.,Ltd. Registration number: 2018510000103 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20230525 Granted publication date: 20141119 Pledgee: Luzhou Talents Innovation and entrepreneurship equity investment fund partnership (L.P.) Pledgor: SICHUAN GUOKANG PHARMACEUTICAL Co.,Ltd. Registration number: 2018510000103 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |